Table 3 Chemical identification of the metabolic features associated with phthalate exposure in the metabolic-wide association study at visit 1 (n = 216) and visit 2 (n = 145) after correction for multiple testing (q < 0.2) using generalized linear models
From: Impact of prenatal phthalate exposure on newborn metabolome and infant neurodevelopment
m/z | rt | Ontology level* | Metabolite | Exposure | Association with exposure (β) | Pathways | Biological function | |
|---|---|---|---|---|---|---|---|---|
Visit 1 (8–14 weeks) n = 216 | ||||||||
181.0733 | 1.62 | OL2a | Tyrosine | MBP | −0.0046 | Tyrosine metabolism (endogenous) | ||
211.0844 | 2.86 | OL2a | 2-amino-3-(4-hydroxy-3-methoxyphenyl) propanoic acid | MBP | 0.0030 | Pharmaceutical (foodome) | Not enough information | |
178.0496 | 3.97 | OL2a | 3-Hydroxyhippuric acid | MBP | 0.0012 | Microbial metabolite (foodome) | Not enough information | |
174.0549 | 6.39 | OL2b | Quinaldic acid | MBP | 0.0031 | Tryptophan metabolism (endogenous) | Not enough information | |
243.1491 | 7.45 | OL1 | Tiglylcarnitine | MBP | 0.0049 | Acyl carnitine metabolism (endogenous) | Not enough information | |
234.0778 | 6 | OL2a | (R)-N-Acetyl-S-(1-(hydroxymethyl)-2-propen-1-yl)-L-cysteine | MBP | −0.0032 | Acrylamide metabolite (environmental) | Acrylamide is classified as a possible human carcinogen; found in cigarettes or processed foods32 | |
105.0335 | 6.69 | OL1 | 4-hydroxybenzaldehyde | MBP | 0.0033 | Biosynthesis of phenyl-propanoids (endogenous) | Promotes antiparasitic host response73 | |
88.0393 | 2.71 | OL2b | Serine | MBP | 0.0021 | Glycine, serine and threonine metabolism (endogenous) | Neurotransmitter precursor23 | |
289.2523 | 16.54 | OL2a | Dihomo-gamma-linolenic acid | MBP | −0.0012 | Linoleic acid metabolism (endogenous) | Neural membrane phospholipid26 | |
330.2554 | 13.25 | OL2b | Docosapentaenoic acid | MBP | −0.0009 | Fatty acid (endogenous) | Anti-inflammatory; found in high concentrations in breastmilk74 | |
243.1127 | 7.6 | OL2a | Oxadixyl | MBP | −0.0022 | Fungicide used in food crops (environmental) | Not enough information | |
215.1178 | 11.1 | OL2a | Melatonin | MBP | 0.0059 | Circadian entrainment (endogenous) | Anti-oxidative effects in newborns75 | |
190.1073 | 8.53 | OL2a | 2-Octenedioic acid | MBP | −0.0018 | Fatty acid (endogenous) | Not enough information | |
360.2741 | 11.69 | OL1 | 3-hydroxydodecanoyl carnitine | MBP | −0.0019 | Acyl carnitine metabolism (endogenous) | Related to fatty acid oxidation and energy metabolism76 | |
193.0737 | 4.28 | OL2b | 3-Methylhippuric acid | MBP | 0.0014 | Xylene metabolite (environmental) | Xylenes are often used as solvents in household products77 | |
777.6937 | 11.82 | OL1 | Thyroxine | MBP | −0.0011 | Tyrosine metabolism (endogenous) | Thyroid hormone; low level associated with increased illness and neurodevelopmental issues in newborns25 | |
259.1073 | 8.58 | OL2a | Linagliptin | MBP | −0.0014 | Dipeptidyl peptidase-4 (DPP-4) inhibitor (drug) | Lowers blood sugar in patients by signaling the liver to stop producing glucose78 | |
193.0972 | 1.55 | OL1 | Trans-3’-Hydroxycotinine | MBP | 0.0048 | Nicotine metabolite (endogenous) | Indicator of exposure to cigarette smoke; inversely associated with birth weight31 | |
157.0608 | 3.3 | OL2b | Formiminoglutamic acid | MBP | 0.0023 | Folate bioavailability (foodome) | Metabolite accumulates with inadequate availability of folate; used as a biomarker of folate deficiency79 | |
197.0185 | 4.86 | OL2a | hydroxyphenylacetic acid | MBP | 0.0022 | Tyrosine metabolism (endogenous) | Not enough information | |
308.0908 | 8.35 | OL2b | Glutathione reduced | MBP | 0.0017 | Glycine, serine and threonine metabolism (endogenous) | Prevents oxidative stress80 | |
156.1019 | 5.87 | OL2b | Acetylleucine | MEHP | 0.0061 | Valine, leucine and isoleucine metabolism (endogenous) | Decreased neural inflammation in mouse models81 | |
199.0962 | 7.23 | OL2a | Phenyllactic acid | MEHP | −0.0057 | Phenylalanine metabolism (endogenous) | Not enough information | |
273.1844 | 10.95 | OL2a | Estradiol-17alpha | MEHP | 0.0080 | Steroid hormone biosynthesis (endogenous) | Reduced chronic inflammation in mouse models82 | |
Visit 2 (24–30 weeks) n = 145 | ||||||||
292.2348 | 16.08 | OL2a | 11-Octadecen-9-ynoic acid | MBP | −0.0113 | Fatty acid (endogenous) | Not enough information | |
237.1232 | 4.38 | OL2a | Tryptophan | MECPP | 0.0044 | Tryptophan metabolism (endogenous) | Essential to brain development and the establishment of sleep-wake cycles in newborns24 | |
218.1386 | 5.74 | OL2a | 15-Valerolactone | MECPP | −0.0039 | Not enough information (endogenous) | Not enough information | |
199.1076 | 8.63 | OL2a | Tyrosine | MECPP | −0.0063 | Tyrosine metabolism (endogenous) | ||
266.136 | 7.83 | OL2a | 5-methyl-1,3-benzenediol | MECPP, MEOHP | 0.0058, 0.0100 | Not enough information (foodome) | Not enough information | |
156.1019 | 5.87 | OL2b | Acetylleucine | MECPP, MEOHP | 0.0029, 0.0055 | Valine, leucine and isoleucine metabolism (endogenous) | Decreased neural inflammation in mouse models81 | |